Nicox
NicOx S.A. is a biopharmaceutical company based in Valbonne, France, focused on the development of innovative treatments for ocular health and other therapeutic areas. The company offers several ophthalmic products, including VYZULTA for open-angle glaucoma and ZERVIATE for allergic conjunctivitis. Its pipeline includes NCX 470, an investigational nitric oxide-donating drug designed to lower intraocular pressure in glaucoma patients, and NCX 4251, a formulation aimed at treating acute exacerbations of blepharitis. NicOx is also exploring NO-donating therapies for inflammation and cardio-metabolic diseases, with various compounds in clinical stages for conditions such as osteoarthritis and respiratory disorders. Collaborative efforts with organizations like Bausch + Lomb and Ironwood Pharmaceuticals enhance its research capabilities. Founded in 1996, NicOx continues to advance its mission to improve ocular health and explore new therapeutic avenues in other medical fields.
Doliage specializes in ophthalmic products, focusing on medical food supplements and pharmaceuticals designed to address various eye conditions. Established in 2004, the company was among the first to develop a supplement specifically for ophthalmology, incorporating the latest scientific research into their formulations. Doliage gained recognition for being the first to combine lutein and omega-3 fatty acids in 2005, a formulation that has since become standard in the field of micronutrition for eye health. Additionally, since 2009, the company's products have included B vitamins, further enhancing their offerings. Doliage's pharmaceutical portfolio includes prescription medications for conditions such as dry eye syndrome, glaucoma, and eye infections, including Euronac, which aids in corneal healing, and Tobrabact Ge, an ocular antibiotic. All Doliage products are manufactured in a controlled pharmaceutical environment to ensure the highest quality standards.
Aciex is focused on developing first-in-class products to fill unmet needs for ophthalmic therapeutics—products that will permit us to build a sustainable ophthalmic franchise. They believe their company is unique in both concept and products and timely in terms of the market, and they are pleased you have chosen to learn more about Aciex.
EuPharmed s.r.l. develops and markets pharmaceutical products, over-the-counter products and parapharmaceuticals, nutraceuticals, and medical devices. It specializes in the ophthalmological sector. The company offers products for the treatment of various ocular pathologies and ophtalmic diseases.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.